Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.22
-0.01 (-0.03%)
At close: Mar 9, 2026, 4:00 PM EDT
38.22
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:20 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.00 billion as of March 9, 2026. Its market cap has increased by 17.07% in one year.
Market Cap
4.00B
Enterprise Value
3.00B
1-Year Change
17.07%
Ranking
Category
Stock Price
$38.22
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.00B, an increase of 609.64%. That is a compound annual growth rate of 29.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amicus Therapeutics | 4.50B |
| TG Therapeutics | 4.32B |
| Structure Therapeutics | 4.09B |
| Ligand Pharmaceuticals | 4.03B |
| Viking Therapeutics | 3.81B |
| Centessa Pharmaceuticals | 3.79B |
| ACADIA Pharmaceuticals | 3.78B |
| ADMA Biologics | 3.67B |